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Meniscal injuries in the vascularized peripheral part of the meniscus have a better healing potential than tears in the central
avascularzonebecausemeniscalhealingprincipallydependsonitsvascularsupply.Severalbiologicalstrategieshavebeenproposed
to enhance healing of the avascular area of the meniscus: abrasion therapy, ﬁbrin clot, organ culture, cell therapy, and applications
of growth factors. However, data are too heterogeneous to achieve deﬁnitive conclusions on the use of these techniques for
routine management of meniscal lesions. Although most preclinical and clinical studies are very promising, they are still at an
experimental stage. More prospective randomised controlled trials are needed to compare the diﬀerent techniques for clinical
results, applicability, and cost-eﬀectiveness.
1.Introduction
The menisci of the knee are two semilunar ﬁbrocartilaginous
structures sitting between the joint surfaces of femoral
condyles and the tibial plateau. Meniscal injuries are a
common and important source of knee dysfunction. Repair
should be considered depending on the type and location
of the meniscal tear [1–3], as meniscal healing principally
depends on the vascular supply of the zone that has been
injured [4]. A rich network of arborizing vessels within the
peripheralcapsularandsynovialattachmentssuppliesvascu-
larizationtothemenisci.Thisperimeniscalnetworkprovides
radial branches to the meniscus. The outer third of the
meniscus is vascularised, showing a good healing capacity.
Given its abundant vascularization, this zone is also called
“red-red zone.” The remaining two-thirds of the meniscus,
respectively called “red-white zone” and “white-white zone,”
have a scanty vascular supply and present a limited ability to
heal spontaneously [4–7].
A meniscal lesion followed by disruption of the struc-
ture in the avascular zone impairs load distribution and
initiates erosion of the adjacent articular surfaces, causing
osteoarthritis (OA) [8–11]. The most common treatment for
lesions of the avascular part of the meniscus is arthroscopic
partialmeniscectomy,whichreducessymptomsbutsimilarly
predisposes patients to OA [12]. Studies have demonstrated
that healing of the knee is inversely related to the amount
of resected meniscal tissue [10, 11, 13, 14]. Meniscal repair
techniquesintheavascularzoneareincontinuousevolution.
This paper covers current knowledge on biological
strategies for the stimulation of meniscal healing after repair.
2. Abrasion Therapy
Rasping of the damaged meniscus in the vascularized par-
ameniscal synovium promotes an injury response and is
one of the most simple and eﬀective strategies to favour
healing [3]. A small incision is performed to produce a
vascular channel that redirects the blood ﬂow from the
vascular zone into the avascular one. Several studies showed
a signiﬁcant diﬀerence in healing between menisci treated2 Stem Cells International
with abrasion therapy and control groups [15, 16]. The
most common techniques of abrasion therapy are rasping
or trephination, in which radially oriented channels are
performed to encourage vascular and cellular migration
from the peripheral vascular portion to the tear site [17–19].
Rasping increases the production of interleukin-I-alpha (IL-
1-alpha), transforming-growth-factor-beta 1 (TGF-beta1),
platelet-derived growth factor (PDGF), and proliferating cell
nuclear antigen (PCNA). This protein network improves
vascular induction and meniscal healing [20]. Neverthe-
less, trephination and rasping procedures may damage the
normal meniscal structure by an additional full thickness-
transverse tear, resulting in poor meniscal function.
3. Fibrin Clot
Fibrin is a ﬁbrous protein produced in response to bleeding
that plays an important role in blood clotting. Fibrin clots
may be used topically or by injection as an haemostatic
agent, binding to several adhesive proteins of diﬀerent cells
[21–33]. The ﬁbrin clot technique acts as a chemotactic
and mitogenic stimulus for reparative cells because of the
presence of several growth factors [34–37]. The ﬁbrin clot
attaches to the exposed collagen caused by the tear and
induces proliferation of ﬁbrous connective tissue [38–44].
This stimulates the development of ﬁbrocartilaginous tissue.
The ﬁbrin clot technique can be used in combination with
abrasion therapy or with meniscal sutures [45–57]. Two
studies in animal models showed that organized ﬁbrous
connective tissue developed into cartilaginous tissue after a
period of 12–24 weeks [58, 59]. A potential disadvantage of
the ﬁbrin clot technique is the diﬃculty of keeping ﬁbrin
clots on the tear without immobilizing the operated leg [60].
4.OrganCulture
Organ culture is a useful model to assess the intrinsic
healing potential of the meniscus excluding the inﬂuence
of microvasculature and the synovium [61–63]. The eﬀects
of cultured meniscal explants in a rabbit model have been
reported [63]. After gross evaluation, each meniscal explant
underwent histological evaluation to study the relationship
between the graft and recipient tissue. Application of this
technique has demonstrated that meniscal tissue presents an
intrinsic healing ability, which is greater in the peripheral
zone of the meniscus than in the inner zone [63]. Regional
diﬀerences in healing potential and extrinsic factors, such
as blood supply, could explain good meniscal healing in the
peripheral zone.
5. Cell Therapy
Human menisci are populated by diﬀerent cell types, re-
sponding diﬀerently to various stimuli released from the
matrix [64, 65]. Diﬀerent cells have already been used in
studies on meniscal healing: mesenchymal stem cells (MSCs)
deriving from synovial or bone marrow, chondrocytes, and
ﬁbrochondrocytes. MSCs are pluripotent cells able to dif-
ferentiate into speciﬁc therapeutic cell types (developmental
plasticity) [66–68]. The eﬀects of bioactive molecules, which
are secreted by MSCs, determine a regenerative microenvi-
ronment that promotes healing of meniscal lesions [69, 70].
The combination of suturing and MSC treatment, combined
or not with ﬁbrin glue, seems to be the most eﬀective
treatment [71].
Zellner et al. [70] reported the eﬃcacy of mesenchymal
stem cells in the repair of meniscal defects in the avascular
zone. Nonprecultured mesenchymal stem cells in hya-lu-
ronan-collagen composite matrices stimulated the develop-
ment of completely integrated meniscus-like repair tissue in
defectsproducedintheavascularzoneofrabbitmenisci[70].
Further studies conﬁrm the production of abundant
extracellular matrix around the cells, restoring a meniscal-
like tissue in the avascular zone [70, 72–75]. These results are
supported by early studies which demonstrated the eﬃcacy
of the association between growth factors and mesenchymal
stem cells within scaﬀold implants to increase proteoglycans
and/or collagen synthesis [70, 76]. Articular autologous
and allogenic chondrocytes have also been used to induce
repair in the avascular part of the meniscus [77, 78].
Peretti et al. described a porcine chondrocyte model where
implantation of such cells was performed in the avascular
part of the meniscus using an allogenic scaﬀold seeded with
autologous chondrocytes. These chondrocytes were eﬀective
in promoting healing meniscal tears [77]. Fibrochondrocytes
showed potential for initiating a reparative response in
meniscal defects through the production of new extracellular
matrix (ECM) [79, 80]. When seeded into a porous collagen
scaﬀold, ﬁbrochondrocytes harvested from the inner avascu-
lar part of the meniscus produce more glycosaminoglycans
(GAGs) than ﬁbrochondrocytes from a peripheral ﬁbrous
location [81, 82]. Although these ﬁndings are encouraging,
the application of autologous ﬁbrochondrocytes in meniscal
tissue engineering is limited by the diﬃculty in harvesting a
suﬃcient number of cells [83–93].
6. Growth Factors
Growth factors act as signalling molecules on target cells to
stimulate the regeneration of damaged tissue [6]. Further-
more, they can induce the synthesis and inhibit degradation
of ECM by a mechanism of downregulation of proteases
[94]. Several studies in vitro and in vivo evaluated the eﬀects
of treatment with speciﬁc growth factors. Two categories
of growth factors in consideration of their biochemical
attributes are generally considered: anabolic and catabolic
growth factors.
6.1. Anabolic Growth Factors
6.1.1. Fibroblast Growth Factor (FGF). basic FGF was used to
stimulate type II collagen and aggrecan mRNA production
in cellular and tissue development [95, 96]. In an ovine
experimental model, meniscal ﬁbrochondrocytes responded
to bFGF by proliferating and producing new extracellularStem Cells International 3
matrix [79]. Another FGF type, FGF-2, stimulates prolif-
eration of the joint chondrocytes, mesenchymal stem cells,
osteoblasts, and adipocytes. Furthermore, it maintains the
ability of any cell types to diﬀerentiate [97, 98]. Moreover,
a hyperexpression of FGF-2 and alpha-smooth muscle actin
(alpha-SMA) through recombinant adeno-associated virus
(rAAV) enhanced cell proliferation and increased survival
rate compared with control groups. However, FGF did not
signiﬁcantly increase the synthesis of major extracellular
matrix components or DNA contents [99].
6.1.2. Transforming-Growth-Factor-Beta (TGF-Beta). TGF-
beta seems to have several regulatory activities, stimulating
collagen and proteoglycan production to increase the attach-
ment of the cells in repaired meniscal tissue. Nevertheless, it
has no eﬀect on cell proliferation [6, 100–103].
6.1.3. Bone Morphogenetic Proteins (BMPs). BMPs are a
group of growth factors belonging to the TGF-β superfamily
playing an important role during embryogenesis and tissue
repair in relation to their osteoinductive properties [104,
105]. BMP-2 acts as a stimulus in the diﬀerentiation of
mesenchymal cells. It also presents a migratory eﬀect in
endothelial cells or smooth muscle cells, but rarely in
chondrocytes [106]. BMP-7 regulates matrix homeostasis
and inhibits the processes of degradation. BMP-7 acts with
diﬀerent chondrogenic agents and is more eﬀective than
BMP-2 in chondrogenic diﬀerentiation of MSCs in promot-
ing meniscal healing [107].
6.1.4. Insulin-Like-Growth-Factor-I (IGF-I). This is consid-
ered the main anabolic growth factor for articular cartilage
[108, 109]. Unlike TGF-beta I, IGF-I increases cell prolifer-
ation signiﬁcantly but has no eﬀect on the attachment [95].
Therefore, a mixture of growth factors in association with
IGF-I could induce an extensive cellular response to mediate
avascular meniscal healing [100].
6.1.5. Vascular Endothelial Growth Factor (VEGF). The
induction of angiogenesis is important to stimulate healing
of meniscal tears [110–122]. Vascular endothelial growth
factor (VEGF) may promote better healing, stimulating an-
giogenesis to improve the healing capacities of meniscus
tissue. In adults, VEGF expression is downregulated by
endostatin, mostly in the avascular zone [123]. However, the
local application of VEGF did not show an improvement of
meniscal healing [124].
6.1.6. Platelet-Derived Growth Factor-AB (PDGF-AB).
PDGF-AB plays an important role in the angiogenesis and
cell development [125, 126]. The application of PDGF-AB
in the peripheral part of the menisci showed a better
healing response than the application in the central part
[127]. However, this anabolic growth factor increased both
cell proliferation and ECM formation in all zones of the
meniscus, including the avascular zone [128].
6.2. Catabolic Growth Factors
6.2.1. Endostatin. Endostatin is an antiangiogenic factor ex-
pressed by ﬁbrochondrocytes in the avascular zone of men-
isci. Endostatin concentrations were higher when ﬁbrochon-
drocytes were in coculture with MSCs, suggesting that men-
iscalcellgrowthis inhibited bytheproliferationofMSCs[7].
6.2.2. Interleukin-I (IL-I). This is a proinﬂammatory cytok-
ine that stimulates the development of a local inﬂammatory
reaction. Meniscal explants treated with IL-I have failed to
show any signs of regeneration [129]. These ﬁndings suggest
that relevant expression of IL-I in association with higher
levels of tumor-necrosis-factor-alpha (TNF-alpha) inhibit
meniscal repair [130].
7.PlateletRichPlasma
Platelet-rich plasma (PRP) is an autologous substance rich
in platelets that releases growth factors from both alpha
and dense granules [131–150]. These growth factors have
been associated with the initiation of a healing cascade
leading to cellular chemotaxis, angiogenesis, collagen matrix
synthesis, and cell proliferation [151]. Ishida et al. reported
the eﬀects of PRP on meniscal tissue regeneration, both
in vitro and in vivo, in a rabbit model. In the in vitro
study, monolayer meniscal cell cultures were prepared and
proliferative behaviour, extracellular matrix (ECM) synthe-
sis, and ﬁbrocartilage-related messenger ribonucleic acid
(mRNA) expressions were assessed in the presence of PRP.
PRP stimulated DNA synthesis, ECM synthesis, and mRNA
expression of biglycan and decorin [152–161]. In the in vivo
study, full-thickness defects were produced in the avascular
region of rabbit meniscus. Gelatin hydrogel (GH) was used
to deliver PRP into the defects. At histology 12 weeks after
surgery, signiﬁcantly better meniscal repair was evident in
animals that received PRP with GH than in the control
groups [162].
In contrast, Zellner et al. evaluated several cell and
biomaterial-based treatment options for repair of defects
in the avascular zone of rabbit menisci by producing
circular meniscal punch defects in the avascular zone
of rabbit menisci. The defects were left empty or ﬁlled
with hyaluronan-collagen composite matrices without cells
loaded with platelet-rich plasma, autologous bone marrow,
or autologous mesenchymal stem cells. Neither bone mar-
row nor platelet-rich plasma loaded in matrices induced
improvement in meniscal healing [70].
8. Discussion
In the last few decades, many studies on meniscal healing
have focused on methods to enhance the healing capacities
of the meniscus after repair [163–178]. Abrasion of the torn
meniscus and synovial tissue or the establishment of vascular
channels to redirect blood ﬂow into the avascular zone
seems to be the preferred treatment [3, 15, 16]. However,
the healing potential depends on the type and location of4 Stem Cells International
the tear and its distance from the peripheral vascularised
zone. The use of a ﬁbrin clot can also be an eﬀective
technique to support a reparative response in the avascular
zone of the meniscus [34, 35, 37]. Findings demonstrated
that the rasping technique is more eﬀective than ﬁbrin clot
application to improve meniscal healing [179]. Kobayashi
et al. reported healing rates in the peripheral zone of the
menisci in an on-organ culture model. Regional diﬀerences
in healing potential and extrinsic factors, such as a blood
supply, could explain the good meniscal healing potential in
the peripheral zone [63].
Cell-based therapy for meniscal tears has signiﬁcantly
contributed to an increasing number of patients treated with
repair techniques rather than meniscectomy. Diﬀerent cell
types have already been used in studies on meniscus healing:
MSCs, articular chondrocytes and autologous ﬁbrochondro-
cytes [70, 77, 81, 82] .P r o g e n i t o rc e l l ss u c ha sm e s e n c h y m a l
stem cells present the advantage of being easily expandable
without losing their diﬀerentiation potential into a variety
of mesenchymal tissues including bone, tendon, cartilage,
muscle, ligament, fat, and marrow stroma [64, 66, 68].
The application of MSCs and their stimulation with growth
factors in combination with a mechanically loadable scaﬀold
have been proposed as the focus of future studies [135, 148].
Several studies reported the eﬃcacy of mesenchymal
stem cells in the repair of meniscal defects in the avascular
zone, with production of abundant extracellular matrix
around the cells and restoration of a meniscal-like tissue
[70, 72–75]. Early studies demonstrated the eﬃcacy of the
association between growth factors and mesenchymal stem
cellswithinscaﬀoldimplantstoincreaseproteoglycanand/or
collagensynthesis[180–196].Therefore,thehealingresponse
of mesenchymal stem cells seems to produce additional
repairqualitiesbesidesthedeliveryofgrowthfactors[70,76].
Many studies have shown the importance of growth
factors in the treatment of meniscal tears of the avascular
portion,butthereisaverycomplexinterplayamongavariety
of factors that inﬂuences healing processes. Growth factors
that promote cell diﬀerentiation and chondrocytic prolif-
eration include both anabolic growth factors (TGF-beta I,
BMPs, IGF-I, FGF, VEGF, and PDGF-AB) and catabolic
growth factors (endostatin, IL-1, and TNF-alpha). Anabolic
growth factors could be of additional value in improving
the healing of meniscal lesions [6, 79, 95–109, 123–128].
However, the application of growth factors remains very
limited in clinical settings [6, 95]. Future research should
focus on the use of tissue-engineered constructs in associa-
tion with diﬀerent growth factors [197–203]. A preparation
rich in growth factors could produce better results than the
use of isolated growth factors. Only a few studies to date
have evaluated the eﬀectiveness of a preparation of platelet-
rich plasma (PRP), but there is some evidence that PRP can
improve healing of the menisci [127, 128]. The release of
growth factors from platelets has been associated with the
initiation of a healing cascade leading to cellular chemotaxis,
angiogenesis,collagenmatrixsynthesis,andcellproliferation
[151, 162]. In contrast, a study in an animal model reported
that application of PRP did not produce improvements in
meniscal healing [70].
9. Conclusion
Patients with meniscal tears report pain and functional
limitation of the knee joint. Partial meniscectomy is the most
common treatment option, but it represents a predisposing
factor for osteoarthritis [12]. To date only limited scientiﬁ-
cally proven management modalities are available. A better
understanding of meniscal healing mechanisms will allow
speciﬁc treatment strategies to be developed. Although most
preclinical and clinical studies are very promising, they are
still at an experimental stage. Further prospective trials are
necessary to compare the diﬀerent techniques for eﬃcacy,
applicability, and cost-eﬀectiveness in the management of
lesions of the avascular region of the meniscus.
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